Literature DB >> 21696328

Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.

Christina Frank1, Dirk Werber, Jakob P Cramer, Mona Askar, Mirko Faber, Matthias an der Heiden, Helen Bernard, Angelika Fruth, Rita Prager, Anke Spode, Maria Wadl, Alexander Zoufaly, Sabine Jordan, Markus J Kemper, Per Follin, Luise Müller, Lisa A King, Bettina Rosner, Udo Buchholz, Klaus Stark, Gérard Krause.   

Abstract

BACKGROUND: We describe an outbreak of gastroenteritis and the hemolytic-uremic syndrome caused by Shiga-toxin-producing Escherichia coli in Germany in May, June, and July, 2011. The consumption of sprouts was identified as the most likely vehicle of infection.
METHODS: We analyzed data from reports in Germany of Shiga-toxin-producing E. coli gastroenteritis and the hemolytic-uremic syndrome and clinical information on patients presenting to Hamburg University Medical Center (HUMC). An outbreak case was defined as a reported case of the hemolytic-uremic syndrome or of gastroenteritis in a patient infected by Shiga-toxin-producing E. coli, serogroup O104 or serogroup unknown, with an onset of disease during the period from May 1 through July 4, 2011, in Germany.
RESULTS: A total of 3816 cases (including 54 deaths) were reported in Germany, 845 of which (22%) involved the hemolytic-uremic syndrome. The outbreak was centered in northern Germany and peaked around May 21 to 22. Most of the patients in whom the hemolytic-uremic syndrome developed were adults (88%; median age, 42 years), and women were overrepresented (68%). The estimated median incubation period was 8 days, with a median of 5 days from the onset of diarrhea to the development of the hemolytic-uremic syndrome. Among 59 patients prospectively followed at HUMC, the hemolytic-uremic syndrome developed in 12 (20%), with no significant differences according to sex or reported initial symptoms and signs. The outbreak strain was typed as an enteroaggregative Shiga-toxin-producing E. coli O104:H4, producing extended-spectrum beta-lactamase.
CONCLUSIONS: In this outbreak, caused by an unusual E. coli strain, cases of the hemolytic-uremic syndrome occurred predominantly in adults, with a preponderance of cases occurring in women. The hemolytic-uremic syndrome developed in more than 20% of the identified cases.

Entities:  

Mesh:

Year:  2011        PMID: 21696328     DOI: 10.1056/NEJMoa1106483

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  385 in total

1.  Induction of Shiga Toxin-Encoding Prophage by Abiotic Environmental Stress in Food.

Authors:  Yuan Fang; Ryan G Mercer; Lynn M McMullen; Michael G Gänzle
Journal:  Appl Environ Microbiol       Date:  2017-09-15       Impact factor: 4.792

Review 2.  Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics.

Authors:  Tania N Petruzziello-Pellegrini; Philip A Marsden
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-07       Impact factor: 2.894

3.  Outbreak of hemolytic uremic syndrome caused by E. coli O104:H4 in Germany: a pediatric perspective.

Authors:  Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2011-12-13       Impact factor: 3.714

4.  Genetic characterization of Escherichia coli O104 isolates from different sources in the United States.

Authors:  Lydia V Rump; Sonya Bodeis-Jones; Jason Abbott; Shaohua Zhao; Julie Kase; Sandra Lorenz; Markus Fischer; Eric Brown; Jianghong Meng
Journal:  Appl Environ Microbiol       Date:  2011-12-30       Impact factor: 4.792

5.  Genomic epidemiology of the Escherichia coli O104:H4 outbreaks in Europe, 2011.

Authors:  Yonatan H Grad; Marc Lipsitch; Michael Feldgarden; Harindra M Arachchi; Gustavo C Cerqueira; Michael Fitzgerald; Paul Godfrey; Brian J Haas; Cheryl I Murphy; Carsten Russ; Sean Sykes; Bruce J Walker; Jennifer R Wortman; Sarah Young; Qiandong Zeng; Amr Abouelleil; James Bochicchio; Sara Chauvin; Timothy Desmet; Sharvari Gujja; Caryn McCowan; Anna Montmayeur; Scott Steelman; Jakob Frimodt-Møller; Andreas M Petersen; Carsten Struve; Karen A Krogfelt; Edouard Bingen; François-Xavier Weill; Eric S Lander; Chad Nusbaum; Bruce W Birren; Deborah T Hung; William P Hanage
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

6.  Performance comparison of benchtop high-throughput sequencing platforms.

Authors:  Nicholas J Loman; Raju V Misra; Timothy J Dallman; Chrystala Constantinidou; Saheer E Gharbia; John Wain; Mark J Pallen
Journal:  Nat Biotechnol       Date:  2012-05       Impact factor: 54.908

Review 7.  Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.

Authors:  Carlamaria Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2017-12-06       Impact factor: 3.714

8.  Characterization of a verocytotoxin-producing enteroaggregative Escherichia coli serogroup O111:H21 strain associated with a household outbreak in Northern Ireland.

Authors:  Tim Dallman; Geoffrey P Smith; Brendan O'Brien; Marie A Chattaway; David Finlay; Kathie A Grant; Claire Jenkins
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

9.  Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice.

Authors:  Jun Fujii; Mariko Naito; Takashi Yutsudo; Sohkichi Matsumoto; Daniel P Heatherly; Takeshi Yamada; Hideyuki Kobayashi; Shin-Ichi Yoshida; Tom Obrig
Journal:  Clin Vaccine Immunol       Date:  2012-10-03

Review 10.  Hemolytic uremic syndrome.

Authors:  Caterina Mele; Giuseppe Remuzzi; Marina Noris
Journal:  Semin Immunopathol       Date:  2014-02-14       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.